ImageneBio (IMA) EBIT Growth (3y) (2023 - 2025)
ImageneBio (IMA) EBIT Growth (3y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.23 Bn | 132.38 Bn | 2.84 Bn | 6.70% |
| 2 | Regeneron Pharmaceuticals | 86.97 Bn | 78.97 Bn | 3.93 Bn | 8.36% |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | 69.02% |
| 4 | Moderna | 59.88 Bn | 54.74 Bn | 52.00 Mn | 24.14% |
| 5 | BeOne Medicines | 42.20 Bn | 37.11 Bn | 1.53 Bn | 44.54% |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 44.34% |
| 7 | BioNTech SE | 28.69 Bn | 10.30 Bn | 668.28 Mn | -28.30% |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 81.27% |
| 9 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - | -18.82% |
| 10 | ImageneBio | 48.35 Mn | -87.00 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -14.16% |
| Jun 30, 2025 | 25.25% |
| Mar 31, 2025 | 29.30% |
| Dec 31, 2024 | -129.39% |
| Sep 30, 2024 | 48.05% |
| Jun 30, 2024 | -7.64% |
| Mar 31, 2024 | -23.31% |
| Dec 31, 2023 | 5.61% |
| Sep 30, 2023 | -46.26% |
| Jun 30, 2023 | -54.04% |
| Mar 31, 2023 | -29.31% |